The shortcomings of Isis/Genzyme's Kynamro were exposed by the broad dark potential risk in this technology.
Antisense and other RNA-based candidates have fail since 1984. Yes, there is no doubt that Isis is over bought at $22.50 . The proof is that the Isis insiders have sold over 400,000 of their freebies recently . Will Yahoo deep six this fact too ? Oh well. Chuckle. : )
I noticed that VICL opened poorly today and got a lot worse. Oh well. Chuckle.: Then I noticed that ISIS message board members did not also follow VICL (as per Yahoo) ## . Chuckle. : Hmmm. I surmised that you travel to a board you do not believe in to tell people not to buy a company going forward to instead to invest in a company going down that you do not believe in. Hmmm. Chuckle, Chuckle..